Andrew R Brownlee1, Erica Bromberg2, Mitchell S Roslin2,3. 1. Department of Surgery, Lenox Hill Hospital, 100 East 77th Street, New York, NY, 10075, USA. brownleeandrew@gmail.com. 2. Department of Surgery, Lenox Hill Hospital, 100 East 77th Street, New York, NY, 10075, USA. 3. Northern Westchester Hospital Center, Mt Kisco, NY, USA.
Abstract
BACKGROUND: In vertical sleeve gastrectomy (VSG), the majority of the stomach is resected and much of the tissue colonized with Helicobacter pylori and the bulk of acid producing cells are removed. In addition, the effect of H. pylori colonization of the stomach of patients undergoing stapling procedures is unclear. As a result, the need for detection and treatment of H. pylori in patients undergoing VSG is unknown. METHODS: Four hundred and eighty patients undergoing VSG are the subject of this study. Three surgeons at a single institution performed the procedures. The remnant stomach was sent to pathology and tested for the presence of H. pylori using immunohistochemistry. All patients were discharged on proton pump inhibitors. RESULTS: Of the 480 patients who underwent VSG, 52 were found to be H. pylori positive based on pathology. There was no statistically significant difference in age (p = 0.77), sex (p = 0.48), or BMI (p = 0.39) between the groups. There were 17 readmissions post-op. Five of these were in the H. pylori positive cohort. Six of these complications were classified as severe (anastomotic leak, intra-abdominal collection, or abscess), with two in the H. pylori positive cohort (Table 1). There was no statistically significant difference in the severe complication rates between the two groups (p = 0.67). There were no readmissions for gastric or duodenal ulceration or perforation. CONCLUSIONS: Our data suggests that there is no increase in early complications in patients with H. pylori undergoing VSG. If these findings are confirmed in a long-term follow-up, it would mean that preoperative H. pylori screening in patients scheduled for VSG is not necessary.
BACKGROUND: In vertical sleeve gastrectomy (VSG), the majority of the stomach is resected and much of the tissue colonized with Helicobacter pylori and the bulk of acid producing cells are removed. In addition, the effect of H. pylori colonization of the stomach of patients undergoing stapling procedures is unclear. As a result, the need for detection and treatment of H. pylori in patients undergoing VSG is unknown. METHODS: Four hundred and eighty patients undergoing VSG are the subject of this study. Three surgeons at a single institution performed the procedures. The remnant stomach was sent to pathology and tested for the presence of H. pylori using immunohistochemistry. All patients were discharged on proton pump inhibitors. RESULTS: Of the 480 patients who underwent VSG, 52 were found to be H. pylori positive based on pathology. There was no statistically significant difference in age (p = 0.77), sex (p = 0.48), or BMI (p = 0.39) between the groups. There were 17 readmissions post-op. Five of these were in the H. pylori positive cohort. Six of these complications were classified as severe (anastomotic leak, intra-abdominal collection, or abscess), with two in the H. pylori positive cohort (Table 1). There was no statistically significant difference in the severe complication rates between the two groups (p = 0.67). There were no readmissions for gastric or duodenal ulceration or perforation. CONCLUSIONS: Our data suggests that there is no increase in early complications in patients with H. pylori undergoing VSG. If these findings are confirmed in a long-term follow-up, it would mean that preoperative H. pylori screening in patients scheduled for VSG is not necessary.
Authors: K Radon; D Windstetter; J Eckart; H Dressel; L Leitritz; J Reichert; M Schmid; G Praml; M Schosser; E von Mutius; D Nowak Journal: Clin Exp Allergy Date: 2004-08 Impact factor: 5.018
Authors: Manish Parikh; Jennifer Liu; Dorice Vieira; Demetrios Tzimas; Daniel Horwitz; Andrew Antony; John K Saunders; Akuezunkpa Ude-Welcome; Adam Goodman Journal: Obes Surg Date: 2016-12 Impact factor: 4.129
Authors: Valentin Mocanu; Jerry T Dang; Noah Switzer; Daniel Skubleny; Xinzhe Shi; Chris de Gara; Daniel W Birch; Shahzeer Karmali Journal: Obes Surg Date: 2018-02 Impact factor: 4.129